News

The latest on managing care, value-based care, insurance markets, payers & providers

Headlines On Deadline...

Men carry a higher average account balance ($1,525) in their health savings accounts and health reimbursement accounts compared to women ($1,321), says the Employee Benefit Research Institute’s “Health Savings Accounts and Health Reimbursement Arrangements: Assets, Account Balances, and Rollovers, 2006–2010.” EBRI attributes this to the fact that men use less health care than women, allowing them to maintain higher account balances.… More than 25 percent of women diagnosed with early ovarian cancer do not receive lymph node biopsies — disheartening because lymph node biopsies can lead to improved survival, say researchers at the University of California–Davis Cancer Center and the California Cancer Registry. They found that 72 percent of patients with early-stage disease had diseased lymph nodes in the pelvis and abdomen. Five-year survival for women who had a node biopsy was 84 percent, compared with only 69 percent of those who did not have the tests. Findings were published in the journal Gynecology Oncology.… The percentage of adults 45 years and older who use a statin to control their cholesterol increased from 2 percent in 1988–1994 to 25 percent in 2005–2008 according to “Health, United States, 2010,” a report prepared by the Centers for Disease Control and Prevention’s National Center for Health Statistics. Half of men ages 65–74 had taken a statin drug in 2005–2008, compared with over one third of women in the same age group.

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

  • Doug Jones and the ACA, Epic misses a White House meeting, and man caves for man-flu sufferers
  • CVS-Aetna deal may trigger merger mania, Johns Hopkins criticized for lack of asthma prevention, & Columbia sees free-ride future for all of its med students

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.